ViewRay Announces Fourth Quarter and Full Year 2022 Results
| VRAYDelisted Stock | USD 0.04 0 5.67% |
Slightly above 62% of ViewRay's investor base is looking to short. The analysis of current outlook of investing in ViewRay suggests that many traders are alarmed regarding ViewRay's prospects. ViewRay's investing sentiment can be driven by a variety of factors including economic data, ViewRay's earnings reports, geopolitical events, and overall market trends.
ViewRay |
ViewRay, Inc. today announced financial results for the fourth quarter and full fiscal year ended December 31, 2022.
Read at finance.yahoo.com
 |
ViewRay Fundamental Analysis
We analyze ViewRay's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ViewRay using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ViewRay based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Sales
Price To Sales Comparative Analysis
ViewRay is currently under evaluation in price to sales category among its peers. Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
ViewRay Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ViewRay stock to make a market-neutral strategy. Peer analysis of ViewRay could also be used in its relative valuation, which is a method of valuing ViewRay by comparing valuation metrics with similar companies.
Peers
ViewRay Related Equities
| CVRX | CVRx | 5.58 | ||||
| DCTH | Delcath Systems | 5.56 | ||||
| BBLG | Bone Biologics | 5.56 | ||||
| HSCS | Heart Test | 2.17 | ||||
| ATEC | Alphatec Holdings | 0.11 | ||||
| AVNS | Avanos Medical | 0.06 | ||||
| AXGN | Axogen | 1.49 | ||||
| INGN | Inogen | 1.63 | ||||
| AORT | Artivion | 1.74 | ||||
| SGHT | Sight Sciences | 2.49 | ||||
| OFIX | Orthofix Medical | 2.69 | ||||
| ESTA | Establishment Labs | 2.81 | ||||
| ANIK | Anika Therapeutics | 3.30 | ||||
| VVOS | Vivos Therapeutics | 6.24 | ||||
| NPCE | Neuropace | 6.26 | ||||
| TIVC | Tivic Health | 7.60 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Consideration for investing in ViewRay Stock
If you are still planning to invest in ViewRay check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ViewRay's history and understand the potential risks before investing.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |